ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix
The prognosis of cervical cancer is linked to lymph node involvement, and this is predicted clinically and pathologically by the stage of the disease, as well as the volume and grade of the tumor. Staging of cervical cancer based on International Federation of Gynecology and Obstetrics (FIGO) stagin...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Radiology 2012-06, Vol.9 (6), p.395-402 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 402 |
|---|---|
| container_issue | 6 |
| container_start_page | 395 |
| container_title | Journal of the American College of Radiology |
| container_volume | 9 |
| creator | Siegel, Cary Lynn, MD Andreotti, Rochelle F., MD Cardenes, Higinia Rosa, MD, PhD Brown, Douglas L., MD Gaffney, David K., MD, PhD Horowitz, Neil S., MD Javitt, Marcia C., MD Lee, Susanna I., MD, PhD Mitchell, Donald G., MD Moore, David H., MD Rao, Gautam G., MD Royal, Henry D., MD Small, William, MD Varia, Mahesh A., MD Yashar, Catheryn M., MD |
| description | The prognosis of cervical cancer is linked to lymph node involvement, and this is predicted clinically and pathologically by the stage of the disease, as well as the volume and grade of the tumor. Staging of cervical cancer based on International Federation of Gynecology and Obstetrics (FIGO) staging uses physical examination, cystoscopy, proctoscopy, intravenous urography, and barium enema. It does not include CT or MRI. Evaluation of the parametrium is limited in FIGO staging, and lymph node metastasis, an important prognostic factor, is not included in FIGO staging. The most important role for imaging is to distinguish stages Ia, Ib, and IIa disease treated with surgery from advanced disease treated with radiation therapy with or without chemotherapy. This article reviews the current role of imaging in pretreatment planning of invasive cervical cancer. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. |
| doi_str_mv | 10.1016/j.jacr.2012.02.021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017616968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1546144012001020</els_id><sourcerecordid>1017616968</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-c8e2563248430846a4b2175555213bd8b297f9d46d70fd0fcf8fb38c7d0684fc3</originalsourceid><addsrcrecordid>eNp9UdFKHDEUDUVRq_5AH8o8-jLbJJPJZEGEZVArCIqt4FvIZG7aTGcz2yS7uD_lR_TLmrDWhz4YLiQ3nHM491yEPhE8I5jwL8NsUNrPKCZ0hnORD-iI1LUoKzZ_2stvxkvCGD5EH0MYMKZNI8QBOqSUV5Tz-gg9LtqHYrFa-WnlrYrgIISi9TZCav-8FPceogcVl-BicT8q56z7UUymuHEbFewGilY5DT5_xZ-pA7-xzydo36gxwOnrfYwery6_t1_L27vrm3ZxW2omSCy1AFonJ0ywCgvGFesoaep0KKm6XnR03ph5z3jfYNNjo40wXSV002MumNHVMTrb6Sb_v9cQolzaoGFMPmFaB5liajjhcy4SlO6g2k8heDAyDbxUfptAGcflIHOcMscpcS6SSJ9f9dfdEvo3yr_8EuB8B4A05caCl0FbSIH01oOOsp_s-_oX_9H1aJ3VavwFWwjDtPYu5SeJDIkgv-WF5n0SijHBFFd_AYr6mt8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017616968</pqid></control><display><type>article</type><title>ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Siegel, Cary Lynn, MD ; Andreotti, Rochelle F., MD ; Cardenes, Higinia Rosa, MD, PhD ; Brown, Douglas L., MD ; Gaffney, David K., MD, PhD ; Horowitz, Neil S., MD ; Javitt, Marcia C., MD ; Lee, Susanna I., MD, PhD ; Mitchell, Donald G., MD ; Moore, David H., MD ; Rao, Gautam G., MD ; Royal, Henry D., MD ; Small, William, MD ; Varia, Mahesh A., MD ; Yashar, Catheryn M., MD</creator><creatorcontrib>Siegel, Cary Lynn, MD ; Andreotti, Rochelle F., MD ; Cardenes, Higinia Rosa, MD, PhD ; Brown, Douglas L., MD ; Gaffney, David K., MD, PhD ; Horowitz, Neil S., MD ; Javitt, Marcia C., MD ; Lee, Susanna I., MD, PhD ; Mitchell, Donald G., MD ; Moore, David H., MD ; Rao, Gautam G., MD ; Royal, Henry D., MD ; Small, William, MD ; Varia, Mahesh A., MD ; Yashar, Catheryn M., MD ; American College of Radiology</creatorcontrib><description>The prognosis of cervical cancer is linked to lymph node involvement, and this is predicted clinically and pathologically by the stage of the disease, as well as the volume and grade of the tumor. Staging of cervical cancer based on International Federation of Gynecology and Obstetrics (FIGO) staging uses physical examination, cystoscopy, proctoscopy, intravenous urography, and barium enema. It does not include CT or MRI. Evaluation of the parametrium is limited in FIGO staging, and lymph node metastasis, an important prognostic factor, is not included in FIGO staging. The most important role for imaging is to distinguish stages Ia, Ib, and IIa disease treated with surgery from advanced disease treated with radiation therapy with or without chemotherapy. This article reviews the current role of imaging in pretreatment planning of invasive cervical cancer. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.</description><identifier>ISSN: 1546-1440</identifier><identifier>EISSN: 1558-349X</identifier><identifier>DOI: 10.1016/j.jacr.2012.02.021</identifier><identifier>PMID: 22632665</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Appropriateness Criteria ; cervical cancer ; Female ; Humans ; imaging ; invasive ; Neoplasm Invasiveness ; Preoperative Care - standards ; pretreatment ; Radiology ; United States ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - surgery</subject><ispartof>Journal of the American College of Radiology, 2012-06, Vol.9 (6), p.395-402</ispartof><rights>American College of Radiology</rights><rights>2012 American College of Radiology</rights><rights>Copyright © 2012 American College of Radiology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-c8e2563248430846a4b2175555213bd8b297f9d46d70fd0fcf8fb38c7d0684fc3</citedby><cites>FETCH-LOGICAL-c481t-c8e2563248430846a4b2175555213bd8b297f9d46d70fd0fcf8fb38c7d0684fc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1546144012001020$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22632665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Siegel, Cary Lynn, MD</creatorcontrib><creatorcontrib>Andreotti, Rochelle F., MD</creatorcontrib><creatorcontrib>Cardenes, Higinia Rosa, MD, PhD</creatorcontrib><creatorcontrib>Brown, Douglas L., MD</creatorcontrib><creatorcontrib>Gaffney, David K., MD, PhD</creatorcontrib><creatorcontrib>Horowitz, Neil S., MD</creatorcontrib><creatorcontrib>Javitt, Marcia C., MD</creatorcontrib><creatorcontrib>Lee, Susanna I., MD, PhD</creatorcontrib><creatorcontrib>Mitchell, Donald G., MD</creatorcontrib><creatorcontrib>Moore, David H., MD</creatorcontrib><creatorcontrib>Rao, Gautam G., MD</creatorcontrib><creatorcontrib>Royal, Henry D., MD</creatorcontrib><creatorcontrib>Small, William, MD</creatorcontrib><creatorcontrib>Varia, Mahesh A., MD</creatorcontrib><creatorcontrib>Yashar, Catheryn M., MD</creatorcontrib><creatorcontrib>American College of Radiology</creatorcontrib><title>ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix</title><title>Journal of the American College of Radiology</title><addtitle>J Am Coll Radiol</addtitle><description>The prognosis of cervical cancer is linked to lymph node involvement, and this is predicted clinically and pathologically by the stage of the disease, as well as the volume and grade of the tumor. Staging of cervical cancer based on International Federation of Gynecology and Obstetrics (FIGO) staging uses physical examination, cystoscopy, proctoscopy, intravenous urography, and barium enema. It does not include CT or MRI. Evaluation of the parametrium is limited in FIGO staging, and lymph node metastasis, an important prognostic factor, is not included in FIGO staging. The most important role for imaging is to distinguish stages Ia, Ib, and IIa disease treated with surgery from advanced disease treated with radiation therapy with or without chemotherapy. This article reviews the current role of imaging in pretreatment planning of invasive cervical cancer. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.</description><subject>Appropriateness Criteria</subject><subject>cervical cancer</subject><subject>Female</subject><subject>Humans</subject><subject>imaging</subject><subject>invasive</subject><subject>Neoplasm Invasiveness</subject><subject>Preoperative Care - standards</subject><subject>pretreatment</subject><subject>Radiology</subject><subject>United States</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - surgery</subject><issn>1546-1440</issn><issn>1558-349X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UdFKHDEUDUVRq_5AH8o8-jLbJJPJZEGEZVArCIqt4FvIZG7aTGcz2yS7uD_lR_TLmrDWhz4YLiQ3nHM491yEPhE8I5jwL8NsUNrPKCZ0hnORD-iI1LUoKzZ_2stvxkvCGD5EH0MYMKZNI8QBOqSUV5Tz-gg9LtqHYrFa-WnlrYrgIISi9TZCav-8FPceogcVl-BicT8q56z7UUymuHEbFewGilY5DT5_xZ-pA7-xzydo36gxwOnrfYwery6_t1_L27vrm3ZxW2omSCy1AFonJ0ywCgvGFesoaep0KKm6XnR03ph5z3jfYNNjo40wXSV002MumNHVMTrb6Sb_v9cQolzaoGFMPmFaB5liajjhcy4SlO6g2k8heDAyDbxUfptAGcflIHOcMscpcS6SSJ9f9dfdEvo3yr_8EuB8B4A05caCl0FbSIH01oOOsp_s-_oX_9H1aJ3VavwFWwjDtPYu5SeJDIkgv-WF5n0SijHBFFd_AYr6mt8</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Siegel, Cary Lynn, MD</creator><creator>Andreotti, Rochelle F., MD</creator><creator>Cardenes, Higinia Rosa, MD, PhD</creator><creator>Brown, Douglas L., MD</creator><creator>Gaffney, David K., MD, PhD</creator><creator>Horowitz, Neil S., MD</creator><creator>Javitt, Marcia C., MD</creator><creator>Lee, Susanna I., MD, PhD</creator><creator>Mitchell, Donald G., MD</creator><creator>Moore, David H., MD</creator><creator>Rao, Gautam G., MD</creator><creator>Royal, Henry D., MD</creator><creator>Small, William, MD</creator><creator>Varia, Mahesh A., MD</creator><creator>Yashar, Catheryn M., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix</title><author>Siegel, Cary Lynn, MD ; Andreotti, Rochelle F., MD ; Cardenes, Higinia Rosa, MD, PhD ; Brown, Douglas L., MD ; Gaffney, David K., MD, PhD ; Horowitz, Neil S., MD ; Javitt, Marcia C., MD ; Lee, Susanna I., MD, PhD ; Mitchell, Donald G., MD ; Moore, David H., MD ; Rao, Gautam G., MD ; Royal, Henry D., MD ; Small, William, MD ; Varia, Mahesh A., MD ; Yashar, Catheryn M., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-c8e2563248430846a4b2175555213bd8b297f9d46d70fd0fcf8fb38c7d0684fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Appropriateness Criteria</topic><topic>cervical cancer</topic><topic>Female</topic><topic>Humans</topic><topic>imaging</topic><topic>invasive</topic><topic>Neoplasm Invasiveness</topic><topic>Preoperative Care - standards</topic><topic>pretreatment</topic><topic>Radiology</topic><topic>United States</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Siegel, Cary Lynn, MD</creatorcontrib><creatorcontrib>Andreotti, Rochelle F., MD</creatorcontrib><creatorcontrib>Cardenes, Higinia Rosa, MD, PhD</creatorcontrib><creatorcontrib>Brown, Douglas L., MD</creatorcontrib><creatorcontrib>Gaffney, David K., MD, PhD</creatorcontrib><creatorcontrib>Horowitz, Neil S., MD</creatorcontrib><creatorcontrib>Javitt, Marcia C., MD</creatorcontrib><creatorcontrib>Lee, Susanna I., MD, PhD</creatorcontrib><creatorcontrib>Mitchell, Donald G., MD</creatorcontrib><creatorcontrib>Moore, David H., MD</creatorcontrib><creatorcontrib>Rao, Gautam G., MD</creatorcontrib><creatorcontrib>Royal, Henry D., MD</creatorcontrib><creatorcontrib>Small, William, MD</creatorcontrib><creatorcontrib>Varia, Mahesh A., MD</creatorcontrib><creatorcontrib>Yashar, Catheryn M., MD</creatorcontrib><creatorcontrib>American College of Radiology</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Siegel, Cary Lynn, MD</au><au>Andreotti, Rochelle F., MD</au><au>Cardenes, Higinia Rosa, MD, PhD</au><au>Brown, Douglas L., MD</au><au>Gaffney, David K., MD, PhD</au><au>Horowitz, Neil S., MD</au><au>Javitt, Marcia C., MD</au><au>Lee, Susanna I., MD, PhD</au><au>Mitchell, Donald G., MD</au><au>Moore, David H., MD</au><au>Rao, Gautam G., MD</au><au>Royal, Henry D., MD</au><au>Small, William, MD</au><au>Varia, Mahesh A., MD</au><au>Yashar, Catheryn M., MD</au><aucorp>American College of Radiology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix</atitle><jtitle>Journal of the American College of Radiology</jtitle><addtitle>J Am Coll Radiol</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>9</volume><issue>6</issue><spage>395</spage><epage>402</epage><pages>395-402</pages><issn>1546-1440</issn><eissn>1558-349X</eissn><abstract>The prognosis of cervical cancer is linked to lymph node involvement, and this is predicted clinically and pathologically by the stage of the disease, as well as the volume and grade of the tumor. Staging of cervical cancer based on International Federation of Gynecology and Obstetrics (FIGO) staging uses physical examination, cystoscopy, proctoscopy, intravenous urography, and barium enema. It does not include CT or MRI. Evaluation of the parametrium is limited in FIGO staging, and lymph node metastasis, an important prognostic factor, is not included in FIGO staging. The most important role for imaging is to distinguish stages Ia, Ib, and IIa disease treated with surgery from advanced disease treated with radiation therapy with or without chemotherapy. This article reviews the current role of imaging in pretreatment planning of invasive cervical cancer. The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22632665</pmid><doi>10.1016/j.jacr.2012.02.021</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1546-1440 |
| ispartof | Journal of the American College of Radiology, 2012-06, Vol.9 (6), p.395-402 |
| issn | 1546-1440 1558-349X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1017616968 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Appropriateness Criteria cervical cancer Female Humans imaging invasive Neoplasm Invasiveness Preoperative Care - standards pretreatment Radiology United States Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - surgery |
| title | ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T19%3A35%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ACR%20Appropriateness%20Criteria%C2%AE%20Pretreatment%20Planning%20of%20Invasive%20Cancer%20of%20the%20Cervix&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Radiology&rft.au=Siegel,%20Cary%20Lynn,%20MD&rft.aucorp=American%20College%20of%20Radiology&rft.date=2012-06-01&rft.volume=9&rft.issue=6&rft.spage=395&rft.epage=402&rft.pages=395-402&rft.issn=1546-1440&rft.eissn=1558-349X&rft_id=info:doi/10.1016/j.jacr.2012.02.021&rft_dat=%3Cproquest_cross%3E1017616968%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017616968&rft_id=info:pmid/22632665&rft_els_id=S1546144012001020&rfr_iscdi=true |